{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:14:00Z","timestamp":1790140440667,"version":"4.0.1"},"reference-count":47,"publisher":"American Diabetes Association","issue":"8","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Type 2 diabetes mellitus (T2DM) is associated with worsened clinical outcomes in hypertrophic cardiomyopathy (HCM) patients. We sought to investigate whether HCM patients with T2DM comorbidity exhibit adverse cardiac alterations in myocardial energetics, function, perfusion, or tissue characteristics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>A total of 55 participants with concomitant HCM and T2DM (HCM-DM) (n = 20) or isolated HCM (n = 20) and healthy volunteers (HV) (n = 15) underwent 31P-MRS and cardiovascular MRI. The HCM groups were matched for HCM phenotype.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Mean \u00b1 SD European Society of Cardiology sudden cardiac death risk scores were comparable between the HCM groups (HCM 2.2 \u00b1 1.5%, HCM-DM 1.9 \u00b1 1.2%; P = not significant), and sarcomeric mutations were equally common. HCM-DM patients had the highest median NT-proBNP levels (HV 42 ng\/L [interquartile range 35\u201366], HCM 298 ng\/L [157\u2013837], HCM-DM 726 ng\/L [213\u20138,695]; P &amp;lt; 0.0001). Left ventricular (LV) ejection fraction, mass, and wall thickness were similar between the HCM groups. HCM-DM patients displayed a greater degree of fibrosis burden with higher scar percentage and lower global longitudinal strain compared with HCM patients. PCr\/ATP (the relative concentrations of phosphocreatine and ATP) was significantly lower in the HCM-DM group than in both HCM and HV (HV 2.17 \u00b1 0.49, HCM 1.93 \u00b1 0.38, HCM-DM 1.54 \u00b1 0.27; P = 0.002). In a similar pattern, stress myocardial blood flow was significantly lower in the HCM-DM group than in both HCM and HV (HV 2.06 \u00b1 0.42 mL\/min\/g, HCM 1.74 \u00b1 0.44 mL\/min\/g, HCM-DM 1.39 \u00b1 0.42 mL\/min\/g; P = 0.002).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>We show for the first time that HCM-DM patients display greater reductions in myocardial energetics, perfusion, and contractile function and higher myocardial scar burden and serum NT-proBNP levels compared with patients with isolated HCM despite similar LV mass and wall thickness and presence of sarcomeric mutations. These adverse phenotypic features may be important components of the adverse clinical manifestation attributable to a combined presence of HCM and T2DM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc22-0083","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T10:01:55Z","timestamp":1657015315000},"page":"1852-1862","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":19,"title":["Coexistent Diabetes Is Associated With the Presence of Adverse Phenotypic Features in Patients With Hypertrophic Cardiomyopathy"],"prefix":"10.2337","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9395-584X","authenticated-orcid":false,"given":"Nicholas","family":"Jex","sequence":"first","affiliation":[{"name":"1Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrit","family":"Chowdhary","sequence":"additional","affiliation":[{"name":"1Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmaine","family":"Thirunavukarasu","sequence":"additional","affiliation":[{"name":"1Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Procter","sequence":"additional","affiliation":[{"name":"2Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshuman","family":"Sengupta","sequence":"additional","affiliation":[{"name":"2Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavithra","family":"Natarajan","sequence":"additional","affiliation":[{"name":"1Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhoora","family":"Kotha","sequence":"additional","affiliation":[{"name":"1Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Poenar","sequence":"additional","affiliation":[{"name":"2Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Swoboda","sequence":"additional","affiliation":[{"name":"1Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xue","sequence":"additional","affiliation":[{"name":"3National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Cubbon","sequence":"additional","affiliation":[{"name":"1Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kellman","sequence":"additional","affiliation":[{"name":"3National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Greenwood","sequence":"additional","affiliation":[{"name":"1Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Plein","sequence":"additional","affiliation":[{"name":"1Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Page","sequence":"additional","affiliation":[{"name":"2Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eylem","family":"Levelt","sequence":"additional","affiliation":[{"name":"1Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"2023053115005851400_B1","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2023053115005851400_B2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"2023053115005851400_B3","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/eurheartj\/ehy625","article-title":"The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy","volume":"40","author":"Wasserstrum","year":"2019","journal-title":"Eur Heart J"},{"key":"2023053115005851400_B4","doi-asserted-by":"crossref","first-page":"11957","DOI":"10.1038\/s41598-017-12289-4","article-title":"Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"2023053115005851400_B5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/CIRCULATIONAHA.109.873273","article-title":"Relationship between coronary microvascular dysfunction and cardiac energetics impairment in type 1 diabetes mellitus","volume":"121","author":"Shivu","year":"2010","journal-title":"Circulation"},{"key":"2023053115005851400_B6","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1161\/01.CIR.0000072789.89096.10","article-title":"Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes","volume":"107","author":"Scheuermann-Freestone","year":"2003","journal-title":"Circulation"},{"key":"2023053115005851400_B7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/eurheartj\/ehv120","article-title":"Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction","volume":"36","author":"Dass","year":"2015","journal-title":"Eur Heart J"},{"key":"2023053115005851400_B8","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","article-title":"Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging","volume":"115","author":"Petersen","year":"2007","journal-title":"Circulation"},{"key":"2023053115005851400_B9","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/eurheartj\/ehv442","article-title":"Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus","volume":"37","author":"Levelt","year":"2016","journal-title":"Eur Heart J"},{"key":"2023053115005851400_B10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jacc.2011.05.018","article-title":"Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations","volume":"58","author":"Olivotto","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2023053115005851400_B11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00259-009-1350-3","article-title":"Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy","volume":"37","author":"Timmer","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023053115005851400_B12","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","article-title":"Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy","volume":"141","author":"Toepfer","year":"2020","journal-title":"Circulation"},{"key":"2023053115005851400_B13","first-page":"jeaa35.296","article-title":"Impact of obesity on myocardial microvasculature assessed using fully-automated inline myocardial perfusion mapping CMR. Eur Heart J Cardiovascular Imaging","volume":"22","author":"Joy","year":"2021"},{"key":"2023053115005851400_B14","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/EJE-17-0724","article-title":"Mechanisms in endocrinology: diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review","volume":"178","author":"Levelt","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"2023053115005851400_B15","doi-asserted-by":"crossref","first-page":"e005539","DOI":"10.1161\/JAHA.117.005539","article-title":"Diabetes mellitus, microalbuminuria, and subclinical cardiac disease: identification and monitoring of individuals at risk of heart failure","volume":"6","author":"Swoboda","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2023053115005851400_B16","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart--an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"2023053115005851400_B17","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2013.05.077","article-title":"T1 mapping for diffuse myocardial fibrosis: a key biomarker in cardiac disease?","volume":"62","author":"Moon","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023053115005851400_B18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12968-017-0355-5","article-title":"Myocardial perfusion cardiovascular magnetic resonance: optimized dual sequence and reconstruction for quantification","volume":"19","author":"Kellman","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2023053115005851400_B19","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O\u2019Hanlon","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2023053115005851400_B20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jacc.2017.12.035","article-title":"Reverse myocardial remodeling following valve replacement in patients with aortic stenosis","volume":"71","author":"Treibel","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023053115005851400_B21","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"2023053115005851400_B22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"2023053115005851400_B23","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.2337\/db21-0270","article-title":"Empagliflozin treatment is associated with improvements in cardiac energetics and function and reductions in myocardial cellular volume in patients with type 2 diabetes","volume":"70","author":"Thirunavukarasu","year":"2021","journal-title":"Diabetes"},{"key":"2023053115005851400_B24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1532-429X-15-91","article-title":"Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update","volume":"15","author":"Kramer","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2023053115005851400_B25","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/CIRCULATIONAHA.117.029895","article-title":"Left ventricular hypertrophy revisited: cell and matrix expansion have disease-specific relationships","volume":"136","author":"Treibel","year":"2017","journal-title":"Circulation"},{"issue":"9","key":"2023053115005851400_B26","doi-asserted-by":"crossref","first-page":"e0185356","DOI":"10.1371\/journal.pone.0185356","article-title":"OXSA: An open-source magnetic resonance spectroscopy analysis toolbox in MATLAB","volume":"12","author":"Purvis","year":"2017","journal-title":"PLoS One"},{"key":"2023053115005851400_B27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/eurheartj\/ehs341","article-title":"Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging","volume":"34","author":"Rider","year":"2013","journal-title":"Eur Heart J"},{"key":"2023053115005851400_B28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jmri.20638","article-title":"Determination of cardiac volumes and mass with FLASH and SSFP cine sequences at 1.5 vs. 3 Tesla: a validation study","volume":"24","author":"Hudsmith","year":"2006","journal-title":"J Magn Reson Imaging"},{"key":"2023053115005851400_B29","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2337\/db18-0112","article-title":"Relation of aortic stiffness to left ventricular remodeling in younger adults with type 2 diabetes","volume":"67","author":"Gulsin","year":"2018","journal-title":"Diabetes"},{"key":"2023053115005851400_B30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023053115005851400_B31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1148\/radiol.2018172613","article-title":"Use of myocardial T1 mapping at 3.0 T to differentiate Anderson-Fabry disease from hypertrophic cardiomyopathy","volume":"288","author":"Karur","year":"2018","journal-title":"Radiology"},{"key":"2023053115005851400_B32","doi-asserted-by":"crossref","DOI":"10.1093\/ehjqcco\/qcac006","article-title":"Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy\/Myocarditis Registry","author":"Lopes","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2023053115005851400_B33","unstructured":"Population estimates. Office for National Statistics, 2021. Accessed 2 March 2022. Available from https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates"},{"key":"2023053115005851400_B34","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/eht070","article-title":"Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy","volume":"34","author":"Coats","year":"2013","journal-title":"Eur Heart J"},{"key":"2023053115005851400_B35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12933-020-01036-1","article-title":"Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy","volume":"19","author":"Wang","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"2023053115005851400_B36","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","article-title":"Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry","volume":"74","author":"Neubauer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023053115005851400_B37","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1161\/CIRCULATIONAHA.121.053527","article-title":"Time to think differently about sarcomere-negative hypertrophic cardiomyopathy","volume":"143","author":"Watkins","year":"2021","journal-title":"Circulation"},{"key":"2023053115005851400_B38","doi-asserted-by":"crossref","first-page":"eabb3991","DOI":"10.1126\/sciadv.abb3991","article-title":"Adiponectin receptor 1 variants contribute to hypertrophic cardiomyopathy that can be reversed by rapamycin","volume":"7","author":"Dhandapany","year":"2021","journal-title":"Sci Adv"},{"key":"2023053115005851400_B39","doi-asserted-by":"crossref","first-page":"290.e1","DOI":"10.1016\/j.ajog.2014.05.011","article-title":"Elevated neonatal insulin-like growth factor I is associated with fetal hypertrophic cardiomyopathy in diabetic women","volume":"211","author":"Gonzalez","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"2023053115005851400_B40","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N Engl J Med"},{"key":"2023053115005851400_B41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamacardio.2019.4268","article-title":"Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy","volume":"5","author":"Fumagalli","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2023053115005851400_B42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjcard.2017.09.026","article-title":"Effect of body mass index on exercise capacity in patients with hypertrophic cardiomyopathy","volume":"121","author":"Larsen","year":"2018","journal-title":"Am J Cardiol"},{"key":"2023053115005851400_B43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/heart.84.5.476","article-title":"Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease","volume":"84","author":"Varnava","year":"2000","journal-title":"Heart"},{"key":"2023053115005851400_B44","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.96.7.2190","article-title":"Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy","volume":"96","author":"Neubauer","year":"1997","journal-title":"Circulation"},{"key":"2023053115005851400_B45","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.jcmg.2018.07.016","article-title":"Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: a systematic review of existing literature","volume":"12","author":"Tower-Rader","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023053115005851400_B46","doi-asserted-by":"crossref","first-page":"e4095","DOI":"10.1002\/nbm.4095","article-title":"Reproducibility of human cardiac phosphorus MRS (31 P-MRS) at 7 T","volume":"32","author":"Ellis","year":"2019","journal-title":"NMR Biomed"},{"key":"2023053115005851400_B47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/nbm.1350","article-title":"Reproducibility of 31P cardiac magnetic resonance spectroscopy at 3 T","volume":"22","author":"Tyler","year":"2009","journal-title":"NMR Biomed"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/8\/1852\/716053\/dc220083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/8\/1852\/716053\/dc220083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T11:02:20Z","timestamp":1685530940000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/45\/8\/1852\/147161\/Coexistent-Diabetes-Is-Associated-With-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,7,26]]},"published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc22-0083","relation":{},"ISSN":["0149-5992"],"issn-type":[{"value":"0149-5992","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,26]]}}}